New research a step closer to male contraceptive pill

(Medical Xpress)—New insights into sperms' swimming skills shed light on male infertility, which affects one in 20 men, and could provide a new avenue to the development of a male contraceptive pill.

In a study published in the journal , researchers from Monash University, the University of Newcastle, John Curtin School of Medical Research and Garvan Institute of Medical Research, in Australia; and the University of Cambridge, in the UK, have shown how a protein called RABL2 affects the length of tails, crippling their motility (or swimming ability), and decreases sperm production.

Professor Moira O'Bryan from Monash University's School of Biomedical Sciences (SOBS) led the research. In , the team found that a mutation in RABL2 resulted in sperm tails that were 17 per cent shorter than normal. Dysfunctioning RABL2 also negatively affected sperm production, resulting in a 50 per cent decrease.

Professor O'Bryan said the research fitted another piece in the jigsaw puzzle of sperm development.

"The mutations in the RABL2 gene are very likely to cause infertility," Professor O'Bryan said.

"Further, as motility is absolutely essential for fertility, insights into tail function may reveal options for urgently needed male-based contraception." 

Lead author and PhD student Jennifer Lo, also from the School of , said RABL2 worked with other molecules known as intraflagellar transport proteins that carry genetic cargo along the sperm tail.

"Intraflagellar are like a train. Our data suggests that the reloading of the train is defective if RABL2 dysfunctions," Ms Lo said.

"The train is still running in sperm tails with dysfunctional RABL2, but it contains fewer passengers. The end result is that sperm formation and motility are abnormal."

Ms Lo said that as mutations in RABL2 decrease sperm count and sperm swimming ability, it may be possible to inhibit this protein in a future male pill.

However, as RABL2 is also found, albeit in lower concentrations, in other tissues, such as the brain, kidney and liver, an inhibitor specific to the testes would need to be developed.

Professor O'Bryan said that was often the canary in the coal mine of general health.

"Many of the basic processes of sperm development occur at lower levels in other organs of the body. As such, the presentation of a man for infertility treatment offers the opportunity not only to give him the children he desires but also to mitigate future disease," Professor O'Bryan said.

More information: www.plosgenetics.org/article/i… journal.pgen.1002969

Related Stories

Researchers Develop Test to Identify 'Best' Sperm

May 20, 2010

(PhysOrg.com) -- Researchers at Yale School of Medicine have discovered a method to select sperm with the highest DNA integrity in a bid to improve male fertility. The method is comparable to that of the egg’s ...

Recommended for you

A nucleotide change could initiate fragile X syndrome

22 hours ago

Researchers reveal how the alteration of a single nucleotide—the basic building block of DNA—could initiate fragile X syndrome, the most common inherited form of intellectual disability. The study appears ...

Gene clues to glaucoma risk

Aug 31, 2014

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

Mutation disables innate immune system

Aug 29, 2014

A Ludwig Maximilian University of Munich team has shown that defects in the JAGN1 gene inhibit the function of a specific type of white blood cells, and account for a rare congenital immune deficiency that ...

Study identifies genetic change in autism-related gene

Aug 28, 2014

A new study from Bradley Hospital has identified a genetic change in a recently identified autism-associated gene, which may provide further insight into the causes of autism. The study, now published online in the Journal of ...

NIH issues finalized policy on genomic data sharing

Aug 27, 2014

The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while ...

User comments